Dementia and BPSD
48 Questions
2 Views

Choose a study mode

Play Quiz
Study Flashcards
Spaced Repetition
Chat to Lesson

Podcast

Play an AI-generated podcast conversation about this lesson

Questions and Answers

What is the formal term for dementia as defined by the DSM-5?

  • Neuropsychiatric Disturbance Syndrome (NDS)
  • Major Neurocognitive Disorder (MND) (correct)
  • Geriatric Cognitive Impairment (GCI)
  • Behavioral and Psychological Symptoms of Dementia (BPSD)

Which of the following is NOT a typical etiology that leads to dementia?

  • Vascular dementia
  • Multiple sclerosis (correct)
  • Lewy body dementia
  • Alzheimer's disease

Behavioral and psychological symptoms of dementia (BPSD) primarily affect which two areas of a patient's life?

  • Nutritional intake and sleep patterns
  • Cardiovascular health and respiratory function
  • Cognitive function and motor skills
  • Functional abilities and quality of life (correct)

Which of the following best describes the nature of BPSD symptoms in relation to psychiatric disorders?

<p>BPSD includes emotional, perceptual, and behavioral disturbances that are similar to those seen in psychiatric disorders (D)</p> Signup and view all the answers

A patient with dementia exhibits sudden, intense fear and believes their caregiver is trying to harm them. Which BPSD symptom is most likely being displayed?

<p>Delusion (C)</p> Signup and view all the answers

Apathy is a common BPSD symptom. Which of the following behaviors would MOST clearly indicate apathy in a dementia patient?

<p>Loss of interest in previously enjoyed hobbies or activities (B)</p> Signup and view all the answers

A clinician is developing a management plan for a dementia patient exhibiting BPSD. What is the MOST critical initial step?

<p>Conducting a comprehensive assessment of potential contributing factors. (C)</p> Signup and view all the answers

An interprofessional team is caring for a patient with dementia and severe agitation. Despite non-pharmacological interventions, the patient's agitation escalates, posing a safety risk. Which factor should the team prioritize when deciding whether to initiate pharmacological treatment for BPSD?

<p>A clearly defined target symptom with measurable outcomes, alongside potential risks/benefits. (B)</p> Signup and view all the answers

Which class of medications, when withdrawn, is least likely to contribute to Behavioral and Psychological Symptoms of Dementia (BPSD)?

<p>Antihistamines (A)</p> Signup and view all the answers

Akathisia, a potential cause of Behavioral and Psychological Symptoms of Dementia (BPSD), can arise from the use of which type of medication?

<p>Second-generation antipsychotics (A)</p> Signup and view all the answers

What percentage range of dementia patients are estimated to experience pain, which is associated with increased Behavioral and Psychological Symptoms of Dementia (BPSD)?

<p>46% to 56% (A)</p> Signup and view all the answers

Which of the following is NOT a recommended approach for assessing comfort in patients with dementia?

<p>Direct questioning without caregiver input (B)</p> Signup and view all the answers

Which of the following tools is specifically designed and validated for objectively evaluating and tracking pain in advanced dementia?

<p>Pain Assessment in Advanced Dementia (PAINAD) scale (D)</p> Signup and view all the answers

Why is establishing a clear baseline critically important when assessing Behavioral and Psychological Symptoms of Dementia (BPSD)?

<p>To have a reference point for assessing treatment effects, given the fluctuating and subjective nature of Behavioral and Psychological Symptoms of Dementia (BPSD). (A)</p> Signup and view all the answers

Which domain is NOT evaluated by the Neuropsychiatric Inventory (NPI) for assessing overall Behavioral and Psychological Symptoms of Dementia (BPSD)?

<p>Cognitive impairment (C)</p> Signup and view all the answers

A patient with dementia exhibits increased agitation and aggression. Initial assessment reveals the patient is on a stable dose of a second-generation antipsychotic. Despite the stable dose, symptoms worsen. Considering the information provided, what is the MOST critical next step?

<p>Assess for akathisia as a potential side effect of the antipsychotic (C)</p> Signup and view all the answers

Which of the following non-pharmacological interventions has demonstrated anecdotal effectiveness in managing agitation?

<p>Providing busy quilts. (A)</p> Signup and view all the answers

What is a significant limitation associated with the use of psychotropic medications in treating BPSD?

<p>They have a high side effect burden and modest benefits. (B)</p> Signup and view all the answers

What percentage range of dementia patients receive analgesics for painful conditions, compared to those without dementia?

<p>20% to 40%, compared to 60% to 80% of similar patients without dementia. (A)</p> Signup and view all the answers

In the context of BPSD treatment, why is the empiric treatment of pain considered a crucial first step?

<p>Because untreated pain has a strong relationship with BPSD. (C)</p> Signup and view all the answers

What was the primary outcome measure used in the multicenter cluster randomized controlled trial that examined the effect of a stepwise protocol for empiric treatment of pain in patients with dementia-related agitation?

<p>Changes in scores on the Cohen-Mansfield Agitation Inventory. (C)</p> Signup and view all the answers

In the 8-week multicenter study on empiric pain treatment for BPSD, what was the magnitude of agitation reduction in the intervention group, and how does this compare to the effect seen with risperidone?

<p>17% reduction, an effect comparable to that seen with risperidone. (D)</p> Signup and view all the answers

A clinician is deciding on a treatment plan for a patient with BPSD who exhibits wandering and repetitive vocalizations. Based on current evidence, which approach is MOST appropriate?

<p>Prioritize non-pharmacological measures, as these symptoms rarely respond to pharmacotherapy. (B)</p> Signup and view all the answers

An elderly patient with dementia is prescribed pregabalin as part of a stepwise protocol for empiric pain management. Which of the following dosages of pregabalin would be LEAST appropriate, considering the study's findings and typical geriatric considerations for medication management?

<p>300 mg daily, as this dosage was used in the original study. (A)</p> Signup and view all the answers

What is the recommended first-line pharmacotherapy for agitated behaviors in patients without Lewy body dementia or Parkinson's disease, after non-pharmacological interventions have been tried?

<p>Citalopram or Sertraline (C)</p> Signup and view all the answers

In patients with Lewy body dementia or Parkinson's disease experiencing agitation, what is the recommended next step if Citalopram or Sertraline are ineffective?

<p>Adding an acetylcholinesterase inhibitor (if not already prescribed) (C)</p> Signup and view all the answers

How often should trials of antipsychotic tapering be attempted?

<p>Every 3 to 6 months (A)</p> Signup and view all the answers

Why should Olanzapine generally be avoided when cross-titrating antipsychotics?

<p>Due to its anticholinergic effects and lower benefit overall (A)</p> Signup and view all the answers

For depression in patients with dementia, what medication is suggested to be added if there is a limited response after an adequate trial of Citalopram or Sertraline?

<p>Methylphenidate (D)</p> Signup and view all the answers

Which neurostimulation therapy has shown benefit in most studies for treatment-refractory patients with dementia?

<p>Repetitive transcranial magnetic stimulation (D)</p> Signup and view all the answers

A patient with Parkinson's disease exhibits agitation. They are already prescribed an acetylcholinesterase inhibitor. Which of the following would be the MOST appropriate next step according to the guidelines?

<p>Trial Pimavanserin or Quetiapine (D)</p> Signup and view all the answers

A patient with severe agitation and aggressive symptoms requires immediate initiation of antipsychotic therapy. Which crucial step should NOT be overlooked despite the initiation of pharmacotherapy?

<p>Implementing additional interventions and attempting discontinuation when the patient stabilizes (C)</p> Signup and view all the answers

Which of the following best describes the focus of the Cohen-Mansfield Agitation Inventory (CMAI)?

<p>Specifically evaluating agitated behaviors, categorized as physical, verbal, aggressive, or non-aggressive. (D)</p> Signup and view all the answers

What is the initial step recommended for managing Behavioral and Psychological Symptoms of Dementia (BPSD), assuming the patient does not pose an immediate danger to themselves or others?

<p>Establishing a baseline by identifying and quantifying target symptoms. (D)</p> Signup and view all the answers

For assessing Behavioral and Psychological Symptoms of Dementia (BPSD), what is considered the most accurate method to gather information from caregivers regarding a patient's symptoms?

<p>Having caregivers maintain a daily prospective diary or calendar. (D)</p> Signup and view all the answers

A patient with dementia is exhibiting aggression and poses a risk of injury to caregivers. Pharmacological interventions have been attempted but have been unsuccessful. Which of the following is the MOST appropriate setting for managing this patient?

<p>Referral to a geropsychiatry unit. (C)</p> Signup and view all the answers

Which of the following scenarios necessitates managing a patient with BPSD in a hospital setting?

<p>The patient requires parenteral medications due to delirium. (A)</p> Signup and view all the answers

A caregiver reports that a patient with dementia frequently resists assistance during dressing, exhibiting distress about 60% of the time, which causes the caregiver significant upset (rated 8 out of 10 on a distress scale). According to the provided information, what is the next recommended step in managing this BPSD?

<p>Implement non-pharmacological interventions and continue to monitor and document instances of resistance and distress. (A)</p> Signup and view all the answers

What is the PRIMARY reason systematic trials of evidence-based pharmacological therapies are considered in the management of BPSD?

<p>To address target symptoms when non-pharmacological interventions are insufficient, and after establishing a baseline. (A)</p> Signup and view all the answers

A researcher aims to comprehensively evaluate the effectiveness of a novel intervention for managing agitation in patients with Alzheimer's disease. Considering the potential differences captured by various assessment tools, which combination of assessments would offer the MOST thorough and nuanced understanding of the intervention's impact on agitation and related BPSD?

<p>Combining the NPI, BEHAVE-AD, and CMAI to capture a broad spectrum of BPSD symptoms in addition to agitation. (D)</p> Signup and view all the answers

Which of the following antipsychotics is generally LEAST preferred in Lewy body dementia and dementia associated with Parkinson's disease due to the risk of worsening motor symptoms?

<p>Risperidone (C)</p> Signup and view all the answers

What special consideration is required when prescribing clozapine?

<p>Special monitoring and reporting is required. (A)</p> Signup and view all the answers

What is the established starting and target dosage of pimavanserin for psychosis related to Parkinson's disease?

<p>Fixed dosage of 34mg for both starting and target. (A)</p> Signup and view all the answers

Patients on antipsychotics should be monitored for adverse motor effects and medication tapering should be attempted how often?

<p>Every 3 to 6 months (A)</p> Signup and view all the answers

According to cited research, what is the approximate percentage of patients on long-term antipsychotics who can be successfully discontinued without a worsening of BPSD?

<p>80% (A)</p> Signup and view all the answers

Which of the following SSRIs has demonstrated effectiveness in improving agitation and aggression in patients, according to a 2011 meta-analysis:

<p>Sertraline (D)</p> Signup and view all the answers

In a study of Citalopram at 30 mg daily versus placebo, what average increase in corrected QT interval was observed in patients?

<p>18 ms (D)</p> Signup and view all the answers

When initiating SSRIs for mild to moderate BPSD in elderly patients, what critical principle from geropsychiatry should guide the dosing strategy?

<p>&quot;Start low, go slow, but go as high as you need to go&quot; (C)</p> Signup and view all the answers

Flashcards

Major Neurocognitive Disorder (MND)

A formal term for dementia, defined by the DSM-5, involving cognitive decline and loss of function.

Behavioral and Psychological Symptoms of Dementia (BPSD)

Neuropsychiatric symptoms like delusions, apathy, anxiety, or disinhibition that accompany dementia.

Common Etiologies of Dementia

Includes Alzheimer's, vascular, frontotemporal, Lewy body, and Parkinson's disease.

Characteristics of BPSD symptoms

Emotional, perceptual, and behavioral disturbances similar to those in psychiatric disorders.

Signup and view all the flashcards

Settings where BPSD May Present

Emergent, inpatient, or outpatient settings.

Signup and view all the flashcards

BPSD Treatment Approaches

Supportive, non-pharmacological, and pharmacological interventions.

Signup and view all the flashcards

Impact of BPSD symptoms

Significantly impact the prognosis and management of dementia.

Signup and view all the flashcards

How is Dementia Diagnosed?

Cognitive decline and a loss of function.

Signup and view all the flashcards

Medications causing BPSD

Antidepressants, benzodiazepines, digoxin, levetiracetam, and muscle relaxants can lead to agitation and apathy.

Signup and view all the flashcards

Medication withdrawal & BPSD

Withdrawal from antidepressants, benzodiazepines, or opioids may induce BPSD.

Signup and view all the flashcards

Akathisia & BPSD

Akathisia, a side effect of antipsychotics, can worsen BPSD symptoms.

Signup and view all the flashcards

Physical discomfort & BPSD

Uncomfortable physical symptoms like pain, constipation, and urinary retention.

Signup and view all the flashcards

Pain & BPSD

Pain is frequently present in dementia patients and correlates with increased BPSD.

Signup and view all the flashcards

PAINAD/FLACC scales

Tools for objectively evaluating and tracking pain in patients with dementia.

Signup and view all the flashcards

Relevant Psychiatric History

Psychotic, mood, anxiety, and post-traumatic stress disorders.

Signup and view all the flashcards

NPI and BEHAVE-AD

Standardized tools like the NPI or BEHAVE-AD, used to establish a clear baseline for assessing treatment effects.

Signup and view all the flashcards

BPSD Assessment

Assess frequency, severity, and distress caused by behavioral symptoms.

Signup and view all the flashcards

BEHAVE-AD Domains

Delusions, hallucinations, activity disturbances, aggression, diurnal rhythm disturbances, tearfulness, depression, and anxiety.

Signup and view all the flashcards

CMAI Categories

Physical, verbal, aggressive, or non-aggressive.

Signup and view all the flashcards

Practical BPSD Assessment

Describe, quantify, and assess distress caused by a specific symptom.

Signup and view all the flashcards

Daily Diary

Record symptoms daily to improve accuracy.

Signup and view all the flashcards

BPSD Intervention

Establish a baseline by identifying and quantifying target symptoms.

Signup and view all the flashcards

Delirium Setting

Medical evaluation and potential parenteral medications are needed.

Signup and view all the flashcards

Geropsychiatry Unit Criteria

Aggression with injury, refusing fluids or basic hygiene, suicidal behavior.

Signup and view all the flashcards

Simple Tasks for Agitation

Simple activities like folding laundry or using busy quilts to calm agitated patients.

Signup and view all the flashcards

Busy Quilts

Lap quilts with items like zippers, Velcro, and beads designed to engage and soothe agitated patients.

Signup and view all the flashcards

Weighted Blankets

Blankets that provide a calming effect, similar to their use with children who have pervasive developmental disorders.

Signup and view all the flashcards

Psychotropic Medications for BPSD

Medications used to treat Behavioral and Psychological Symptoms of Dementia (BPSD), but carry a high risk of side effects.

Signup and view all the flashcards

Treating Wandering and Vocalizations

Non-drug approaches are preferable for wandering and repetitive vocalizations.

Signup and view all the flashcards

Empiric Treatment of Pain

An approach where pain is treated even if not explicitly reported, due to the high prevalence of under-treated pain in dementia patients.

Signup and view all the flashcards

Stepwise Protocol for Pain Treatment

Routine acetaminophen (3 g daily), stepped up to low-dose morphine, buprenorphine patch, or pregabalin, if needed.

Signup and view all the flashcards

Pain Relief and Agitation

Reducing pain can reduce agitation without sedating patients.

Signup and view all the flashcards

Antipsychotic use in Lewy body and Parkinson's Dementia

Atypical antipsychotics (Quetiapine, Pimavanserin, Clozapine) are preferred in Lewy body dementia and Parkinson's related dementia due to lower risk of worsening motor symptoms.

Signup and view all the flashcards

Clozapine: Monitoring

Requires monitoring and reporting due to potential side effects.

Signup and view all the flashcards

Pimavanserin (Nuplazid)

Approved for psychosis in Parkinson's disease in the US, but carries a 'black box' warning.

Signup and view all the flashcards

Pimavanserin Dosage

34 mg is both the starting and target dose.

Signup and view all the flashcards

Antipsychotics: Risks

Prolongs the QT interval and has a black box warning for increased mortality risk in elderly dementia patients.

Signup and view all the flashcards

Antipsychotic Medication Monitoring

Regular monitoring for motor side effects and attempts to taper/discontinue are needed.

Signup and view all the flashcards

SSRIs for Agitation/Aggression

SSRIs like citalopram and sertraline may improve agitation and aggression with similar adverse effects to placebo.

Signup and view all the flashcards

SSRI Dosing in BPSD

Start low (Citalopram 10mg, Sertraline 25mg), titrate slowly. Rapid titration can worsen agitation.

Signup and view all the flashcards

Ineffective Intervention

Stop ineffective medication after a suitable trial and document the lack of benefit.

Signup and view all the flashcards

First-Line for Agitation

Start with Citalopram or Sertraline for agitated behaviors after addressing environmental and non-drug approaches

Signup and view all the flashcards

Risperidone or Aripiprazole

Second-line treatment when Citalopram/Sertraline fails, but not in Lewy body dementia or Parkinson's.

Signup and view all the flashcards

Agitation in LBD/PD

Consider acetylcholinesterase inhibitors, Pimavanserin, or Quetiapine.

Signup and view all the flashcards

Antipsychotic Tapering

Every 3-6 months, or sooner if adverse effects emerge.

Signup and view all the flashcards

Switching Antipsychotics

Cross-titrate, but avoid Olanzapine due to anticholinergic effects.

Signup and view all the flashcards

Depression Treatment

Citalopram or Sertraline, consider adding Methylphenidate for limited response.

Signup and view all the flashcards

Refractory Treatment Options

rTMS may be beneficial; ECT is highly effective for depression/aggression.

Signup and view all the flashcards

Study Notes

  • Dementia is a term for major neurocognitive disorder, diagnosed by cognitive decline and impaired daily function, as defined by the DSM-5.
  • Etiologies of dementia include Alzheimer's, vascular, frontotemporal, Lewy body, and Parkinson's diseases.
  • Behavioral and psychological symptoms of dementia (BPSD) involve neuropsychiatric disturbances impacting the management and prognosis of dementia. Non-pharmacological and pharmacological interventions can improve symptoms.
  • BPSD includes emotional, perceptual, and behavioral disturbances which can be classified into cognitive/perceptual, motor, verbal, emotional, and vegetative domains.

Etiology of BPSD

  • BPSD arises from interactions between biology, prior experiences, and the environment.
  • Agitation, disinhibition, and psychosis in dementia are linked to reduced volume and metabolism in brain areas regulating emotion, self-awareness, and perception.
  • Neurotransmission imbalances of cholinergic, noradrenergic, dopaminergic, serotonergic, and glutamatergic systems are correlated with BPSD.
  • Non-biological factors contributing to BPSD are neuroticism, pre-morbid PTSD, poor caregiver communication, and sensory over or under stimulation.
  • Environmental factors could also include unmet needs, learning or behavior factors, and an environment that doesn't match a caregiver's capabilities.

Epidemiology

  • In 2016, dementia affected approximately 43.8 million people globally, a 117% increase from 1990, making it the world's fifth leading cause of mortality
  • Up to 97% of community-dwelling dementia patients will experience BPSD, with symptom severity increasing over time and correlating with institutional placement
  • Delusions are common in Alzheimer's, depression and apathy in vascular dementia, and disinhibition/eating disturbances in frontotemporal dementia.

History and Physical Examination

  • Goal of history intake for BPSD is to establish priorities, characterize symptoms, and identify reversible exacerbating factors
  • Physical exam confirms historical data and identifies alternative contributing conditions
  • "Sundowning," where behavioral disturbances worsen in the evening, affects up to two-thirds of dementia patients.
  • Delusions are commonly paranoid, such as Capgras or Othello syndrome as well as agitation, aggression, wandering, apathy, disinhibition, and sleep disturbances.
  • Physical exam focuses on identifying factors worsening BPSD, such as delirium or discomfort, assessing level of consciousness or signs of pain. Physical findings like fever, hypoxia, abdominal tenderness, fluid overload, inflammation, or neurologic deficits may indicate delirium.

Evaluation

  • Acute or subacute onset of symptoms warrants basic studies such as CBC, electrolytes, liver/kidney function tests, urinalysis, thyroid function tests, toxicology screen, and head CT.

Prioritization

  • Characterize the symptoms; patients endangering themselves or others may require hospitalization
  • Assess safety: assess aggressive behaviors, property damage, and refusal of basic care.
  • Identify delirium: determine the likely underlying medical cause, as treatment in an inpatient setting is likely required

Characterize the Symptoms

  • Caregivers should describe what they see rather than using generic terms that different people might interpret differently.
  • Determine onset, frequency, timing, duration, trajectory, and association with environmental/medication changes

Assess Comfort

  • Because pain is present in 46% to 56% of patients with dementia, it is important to review the patient's medical history for painful conditions and ask caregivers about the patient's self-reported pain and any nonverbal signs.
  • Assessment tools include the Pain Assessment in Advanced Dementia (PAINAD) or Face, Legs, Activity, Cry, Consolability (FLACC) scale.

Create a Baseline

  • Clinicians can use a standarized instrument such as the Neuropsychiatric Inventory (NPI) or the Behavioral Pathology in Alzheimer Disease Rating Scale (BEHAVE-AD).

Treatment

  • Treatment includes appropriate setting selection, treating discomfort, non-pharmacological interventions, and systematic pharmacological trials

Non-Pharmacological Interventions

  • Useful for mild BPSD
  • Includes caregiver training, environmental modifications, and activity adaptations
  • Alzheimer Association can provide modules and in-person training classes

Pharmacological Interventions

  • Psychotropic medications may be used to treat BPSD, but side effects may outweigh benefits
  • Empiric treatment of pain: Patients can be started on 3g of acetaminophen daily for pain relief
  • Antipsychotics: Risperidone, Olanzapine, Quetiapine and Aripiprazole and can be used to treat agitation and aggression

Differential Diagnosis

  • Delirium demonstrates acute onset, fluctuating course, and the presence of an underlying medical condition, medication or psychoactive substance, or medication withdrawal
  • Presentations of psychiatric conditions, such as schizophrenia, bipolar disorder, major depressive disorder, and post-traumatic stress disorder, may be quite similar to BPSD

Prognosis

  • BPSD correlates with more rapid progression of dementia and earlier mortality; whether the treatment has any impact on these variables is unknown

Complications

  • Predict more rapid cognitive decline and earlier mortality
  • Associated with increased hospital length of stay, hospital complications, earlier nursing home placement, and increased rates of psychiatric and cardiovascular disorders in family caregivers

Enhancing Healthcare Team Outcomes

  • Effective management of BPSD requires a coordinated interprofessional healthcare team that partners with the patient's home caregiver
  • Each member of the healthcare team has varying expertise and are responsible for maintaining clear communication, informing everyone regarding any concerns or new developments, and addressing safety risks.

Deterrence and Patient Education

  • Strategies that have been shown to reduce the risk of cognitive decline and the development of dementia, include Both a dietary intervention combining a Mediterranean Diet with the Dietary Approach to Systolic Hypertension (DASH) and pharmacological treatment for hypertension

Studying That Suits You

Use AI to generate personalized quizzes and flashcards to suit your learning preferences.

Quiz Team

Related Documents

Description

Explore dementia's formal definition, typical etiologies and impact. Understand Behavioral and Psychological Symptoms of Dementia (BPSD), focusing on symptoms like apathy and fear. Learn critical steps for managing BPSD, prioritizing safety and interprofessional collaboration.

More Like This

Dementia and BPSD: Symptoms and Management
45 questions
BPSD normaal toets
63 questions
BPSD en Dementie
48 questions

BPSD en Dementie

HeavenlySynecdoche avatar
HeavenlySynecdoche
Use Quizgecko on...
Browser
Browser